Mark Massaro
Stock Analyst at BTIG
(2.44)
# 2,316
Out of 4,748 analysts
139
Total ratings
53.85%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $7.88 | +14.29% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $55.40 | +35.38% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $5.75 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $12.70 | -44.88% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $5.22 | +34.10% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $173.14 | +29.95% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $174.54 | -22.65% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $2.97 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $79.87 | -43.66% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $49.73 | +0.55% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $426.46 | +36.00% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $14.86 | +41.32% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.70 | +70.21% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.45 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.92 | +316.67% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.55 | +125.35% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $28.21 | +6.36% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.07 | +22.80% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $23.38 | +6.93% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.02 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $0.91 | +286.74% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.22 | - | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.06 | +4,761.21% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.33 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $133.13 | +125.34% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $72.13 | -30.68% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $164.25 | -31.81% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $252.50 | -34.65% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $43.41 | +84.29% | 9 | Sep 10, 2018 |
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $7.88
Upside: +14.29%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $55.40
Upside: +35.38%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.75
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $12.70
Upside: -44.88%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $5.22
Upside: +34.10%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $173.14
Upside: +29.95%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $174.54
Upside: -22.65%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.97
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $79.87
Upside: -43.66%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $49.73
Upside: +0.55%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $426.46
Upside: +36.00%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $14.86
Upside: +41.32%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $4.70
Upside: +70.21%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.45
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.92
Upside: +316.67%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.55
Upside: +125.35%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $28.21
Upside: +6.36%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.07
Upside: +22.80%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $23.38
Upside: +6.93%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.02
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.91
Upside: +286.74%
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.06
Upside: +4,761.21%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $1.33
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $133.13
Upside: +125.34%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $72.13
Upside: -30.68%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $164.25
Upside: -31.81%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $252.50
Upside: -34.65%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $43.41
Upside: +84.29%